Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0002-9343(96)80140-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Risk Factors for the Development of Olecranon Bursitis-A Large-Scale Population-Based Study.
J Clin Med
December 2024
Roth|McFarlane Hand & Upper Limb Centre, St. Joseph's Hospital and Western University, London, ON N6A 4V2, Canada.
Olecranon bursitis (OB) involves fluid accumulation in the bursa, with common causes being trauma and preexisting conditions. Its incidence is difficult to quantify, and risk factors such as diabetes, obesity, and male gender are frequently noted. Hyperlipidemia has been linked to musculoskeletal disorders, but its role as a risk factor for OB remains unexplored.
View Article and Find Full Text PDFClinical efficacy of endoscopic debridement combined with compression suture in the treatment of recalcitrant aseptic olecranon bursitis.
J Orthop Surg Res
September 2024
Department of Orthopaedics, Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, 1558 North Sanhuan Road, Wuxing District, Huzhou, 313000, Zhejiang, China.
Article Synopsis
- The study aims to evaluate how effective endoscopic debridement combined with compression sutures is for treating aseptic olecranon bursitis in patients.
- Researchers analyzed data from 28 patients and measured pain levels, elbow function, complications, recurrence, and scarring over an average follow-up period of around 12 months.
- Results showed significant improvements in pain and elbow function post-surgery, with no recurrences or major complications, highlighting the treatment's benefits of being minimally invasive and facilitating quick recovery.
Chronic Bilateral Olecranon Bursitis: A Case Report.
Cureus
July 2024
Orthopedics, Arras Hospital, Arras, FRA.
Article Synopsis
- Olecranon bursitis mainly impacts men aged 30 to 60 and can be acute or chronic in nature.
- Treatment for acute cases is usually simple, but chronic cases can be more difficult to manage.
- The publication presents a rare case of bilateral chronic olecranon bursitis and explores the reasoning behind selecting the most effective treatment option.
Intrabursal Doxycycline Sclerotherapy for Recurrent Olecranon Bursitis of the Elbow: A Case Control Study.
J Hand Surg Glob Online
July 2024
Mayo Clinic, Department of Orthopaedic Surgery, Rochester, MN.
Article Synopsis
- The study investigated the use of doxycycline injections as a treatment for persistent olecranon bursitis (OB) that didn’t respond to standard care, comparing it to surgical removal of the bursa.
- Researchers analyzed data from 27 patients treated with doxycycline and 18 who underwent surgery over an 11-year period.
- Results showed that doxycycline had a recurrence rate of 29.6% and high satisfaction levels (85.7%), while surgery had a lower recurrence rate of 16.7%, indicating that doxycycline may be a safe and effective non-surgical alternative for OB treatment.
A Case of Bilateral Cryptococcal Olecranon Bursitis.
Cureus
July 2024
Obstetrics and Gynaecology, Mater Dei Hospital, Msida, MLT.
Article Synopsis
- - Non-septic olecranon bursitis (NSOB) is inflammation of the olecranon bursa that usually resolves on its own, while septic olecranon bursitis (SOB) is caused by bacterial infections and presents with serious systemic symptoms needing medical attention.
- - A case study highlighted a 24-year-old woman with disseminated cryptococcal infection due to bilateral SOB, which is uncommon in healthy individuals; she underwent surgery and received antifungal treatment, leading to positive outcomes.
- - Infections like SOB from rare pathogens can be tricky to diagnose, especially in immunocompetent patients, making it essential to involve specialists for proper management and to prevent long-term complications.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!